Carolinas Wealth Consulting’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-388
| Closed | -$320K | – | 536 |
|
|
2025
Q1 | $320K | Buy |
388
+154
| +66% | +$127K | 0.07% | 133 |
|
|
2024
Q4 | $180K | Sell |
234
-34
| -13% | -$26.2K | 0.04% | 191 |
|
|
2024
Q3 | $237K | Sell |
268
-52
| -16% | -$45.9K | 0.04% | 168 |
|
|
2024
Q2 | $289K | Buy |
320
+40
| +14% | +$36.2K | 0.06% | 146 |
|
|
2024
Q1 | $218K | Sell |
280
-40,996
| -99% | -$31.9M | 0.04% | 165 |
|
|
2023
Q4 | $261K | Buy |
41,276
+26
| +0.1% | +$164 | 0.06% | 133 |
|
|
2023
Q3 | $237K | Sell |
41,250
-257
| -0.6% | -$1.48K | 0.06% | 132 |
|
|
2023
Q2 | $327K | Sell |
41,507
-185
| -0.4% | -$1.46K | 0.06% | 131 |
|
|
2023
Q1 | $314K | Buy |
41,692
+13
| +0% | +$98 | 0.07% | 132 |
|
|
2022
Q4 | $327K | Buy |
41,679
+1
| +0% | +$8 | 0.07% | 127 |
|
|
2022
Q3 | $293K | Sell |
41,678
-179
| -0.4% | -$1.26K | 0.07% | 121 |
|
|
2022
Q2 | $352K | Buy |
41,857
+41,198
| +6,252% | +$346K | 0.09% | 108 |
|
|
2022
Q1 | $189K | Sell |
659
-4
| -0.6% | -$1.15K | 0.04% | 176 |
|
|
2021
Q4 | $183K | Sell |
663
-162
| -20% | -$44.7K | 0.04% | 184 |
|
|
2021
Q3 | $191K | Buy |
825
+141
| +21% | +$32.6K | 0.04% | 163 |
|
|
2021
Q2 | $157K | Buy |
684
+111
| +19% | +$25.5K | 0.03% | 200 |
|
|
2021
Q1 | $107K | Sell |
573
-284
| -33% | -$53K | 0.03% | 244 |
|
|
2020
Q4 | $145K | Buy |
857
+18
| +2% | +$3.05K | 0.04% | 181 |
|
|
2020
Q3 | $124K | Buy |
839
+652
| +349% | +$96.4K | 0.04% | 169 |
|
|
2020
Q2 | $31K | Buy |
+187
| New | +$31K | 0.01% | 250 |
|